Assisted Reproductive Tech is categorized under Medical Labs in Encino, CA and active since 2004.
Assisted Reproductive Tech was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Natalia Balova, Office Manager at the company’s single location by writing to 5353 Balboa Boulevard # 301, Encino, California CA 91316 or by phoning (818) 986-1070. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Assisted Reproductive Tech |
| Contact Person: | Natalia Balova, Office Manager |
| Address: | 5353 Balboa Boulevard # 301, Encino, California 91316 |
| Phone Number: | (818) 986-1070 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 6211110 |
| Share This Business: |
Assisted Reproductive Tech was started in 2004 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Natalia Balova, Office Manager for inquiries that concern Assisted Reproductive Tech by calling the company number (818) 986-1070, as your correspondence is most welcome. Additionally, the physical location of the single location of Assisted Reproductive Tech can be found at the coordinates 34.16917,-118.5025 as well as the street address 5353 Balboa Boulevard # 301 in Encino, California 91316.
For its online presence, you may visit Assisted Reproductive Tech’s website at and engage with its social media outlets through on Twitter and on Facebook.